LSBCF (LakeShore Biopharma Co) Selling, General, & Admin. Expense: $54.60 Mil (TTM As of Mar. 2025)


What is LakeShore Biopharma Co Selling, General, & Admin. Expense?

LakeShore Biopharma Co LSBCF Selling, General, & Admin. Expense is $54.60 Mil as of Mar. 2025.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. LakeShore Biopharma Co's selling, general, & admin. expense for the six months ended in Mar. 2025 was $25.22 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Mar. 2025 was $54.60 Mil.


LakeShore Biopharma Co  (OTCPK:LSBCF) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


LakeShore Biopharma Co Selling, General, & Admin. Expense Related Terms


LakeShore Biopharma Co Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Selling, General, & Admin. Expense Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Selling, General, & Admin. Expense
32.00 42.99 48.32 59.45 53.90

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only 19.33 30.87 28.16 29.38 25.22

LSBCF vs ACUT, PPCB, ENSC: Selling, General, & Admin. Expense Comparison

For the Biotechnology subindustry, LakeShore Biopharma Co's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LakeShore Biopharma Co Selling, General, & Admin. Expense vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, LakeShore Biopharma Co's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where LakeShore Biopharma Co's Selling, General, & Admin. Expense falls into.



LakeShore Biopharma Co Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $54.60 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of $54.60 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Selling, General, & Admin. Expense of $54.60 Mil as of Mar. 2025. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Selling, General, & Admin. Expense too high?
LakeShore Biopharma Co's current Selling, General, & Admin. Expense is $54.60 Mil.
How does LakeShore Biopharma Co's Selling, General, & Admin. Expense compare to ACUT and PPCB?
LakeShore Biopharma Co's Selling, General, & Admin. Expense of $54.60 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Biotechnology company?
A good Selling, General, & Admin. Expense depends on the Biotechnology industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Selling, General, & Admin. Expense is $54.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Selling, General, & Admin. Expense of $54.60 Mil. The current Selling, General, & Admin. Expense is $54.60 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Selling, General, & Admin. Expense is $54.60 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.